14 March 2026 - 15 March 2026
CloserStill Media,France
Where HIPAA Ends and PCI Begins During the Payment Process
The global healthcare industry relies on data, and its pools are endlessly increasing. It’s estimated that as much as 30% of the world’s data volume comes from healthcare alone, accounting for medical records, personally identifiable health information, and cardholder data. With this data usage always growing, there is a critical need to carefully manage and safeguard information stored and processed.
Optimizing Cold Chain Management for Temperature-Sensitive Pharmaceuticals
Prior to the COVID-19 pandemic, the temperature-controlled pharmaceutical supply chain was a somewhat niche industry. However, the urgent need for temperature-controlled storage and transportation of the COVID-19 vaccines accelerated the development of the pharmaceutical cold chain. At the same time, demand for temperature-sensitive pharmaceuticals such as biologics
The Evolving Role of Personal Protective Equipment in Biopharmaceutical Manufacturing
Personal protective equipment (PPE) plays a critical role in ensuring worker safety and maintaining product integrity in biopharmaceutical manufacturing. With the increasing complexity of production, the need for advanced and reliable PPE solutions has never been so great. However, with more than 5.5 million people employed within the industry worldwide, there is a comprehensive network of regulatory standards and evolving safety protocols that aim to minimize contamination
Pharmaceutical Innovations in Managing Chronic Conditions for the Elderly
As the population ages the prevalence of chronic conditions among the elderly continues to rise. According to the National Council on Aging, 94.9% of adults aged 60 and older have at least one condition, while 78.7% have two or more. This poses significant challenges for both patients and healthcare providers. However, the pharmaceutical industry is stepping up to play a crucial role in developing innovative solutions to manage
Cyber Threats in Pharmaceutical Manufacturing: How to Secure Critical Operations
Across the pharmaceutical manufacturing industry, brands and companies are experiencing a stark wake-up call about data security. Thanks to the highly sensitive data stored by drug research and biotechnology companies, their operations are becoming increasingly appealing to cyber criminals. High-profile firms such as Sun Pharmaceuticals, based in India, have reported cyber attacks that have leaked thousands of sensitive customers
BD is investing $110 million to expand the production of prefillable syringes at its site in Columbus, Nebraska. The investment aims to strengthen the...
Alnylam Pharmaceuticals has announced plans to expand its manufacturing plant in Norton, Massachusetts, USA. The company will invest $250 million to a...
AbbVie has announced the beginning of construction on a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass. The site serv...
Eli Lilly and Company (NYSE: LLY) has announced plans to invest more than $1.2 billion to expand and modernise its Lilly del Caribe manufacturing site...
Pharma USA 2026
16 March 2026 - 17 March 2026
Reuters Events,USA
Reuters Events,USA
Pharma Supply Chain & Security World 2026
18 March 2026 - 19 March 2026
Corvus Global Events,UK
Corvus Global Events,UK
AI Convergence: Small Molecule Discovery Summit
18 March 2026 - 20 March 2026
Hanson Wade Ltd,USA
Hanson Wade Ltd,USA
EMA Invites Large Pharmaceutical Companies to Apply for Portfolio and Technology Meetings...
The European Medicines Agency (EMA) has issued an open invitation to large pharmaceutic...
Zuellig Pharma Acquires Cialis (Tadalafil) Distribution Rights from Eli Lilly in Three Add...
Zuellig Pharma, a leading pharmaceutical distribution and logistics provider in Asia, a...
EU Parliament Adopts Critical Medicines Act to Boost Manufacturing and Tackle Supply Short...
The European Parliament's recent adoption of the Critical Medicines Act represents a pi...
Eisai to Present Latest Data on Long-Term Real-World Treatment with Lecanemab at AD/PD 202...
Eisai Co., Ltd., a leading Japanese pharmaceutical company focused on human health care...
Sanofi Secures First-in-Class JAK Inhibitor Rovadicitinib via $1.5 Billion Licensing Deal...
Sanofi, a leading global pharmaceutical company, has strategically expanded its haemato...
Jiangsu Hengrui Pharmaceuticals Emerges as China's Leading Global Biopharma Contender with...
Jiangsu Hengrui Pharmaceuticals, a cornerstone of China's burgeoning biopharmaceutical...
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
GenScript announced the official opening of its first European mRNA production site in Del...
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APA...
Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract D...
Curatis and Neupharma announce exclusive licensing agreement to develop and market corti...
Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceu...
Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Adva...
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. (...
Shamal Fernando
Managing Director at Slim Pharmaceuticals (Pvt) Ltd, SriLanka, Chartered Marketer , Commercial Leader in Healthcare, Professional Trainer, Pharmaceutical Marketer & Leading Pharmaceutical Importer
Slim Pharmaceuticals ( Pvt) Ltd
Innovations in drug discovery processes
Revolutionizing Medicine: Harnessing the Power of AI in Clinical Trials and Quality Management Systems
Addressing challenges in global supply chain logistics.
Exploring Innovations and Opportunities in the EU CMC Market: A Deep Dive into API and FDF Solutions
Bhupinder Singh Interview - CEO at Messe Muenchen India Pvt. Ltd.
Testimonials
Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.
Informa Markets - Asst Exhibition Sales Manager
.
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
.webp)
.webp)
.webp)
.webp)
.webp)
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
